Follow the あすか製薬ホールディングス株式会社 stock price and the full directors' dealings record of the company, a listed equity based in Japan. Shares are quoted on the JP market, under the authority of EDINET (Japan FSA). Operating in the Banks sector, あすか製薬ホールディングス株式会社 has published 15 insider filings. Market capitalisation: €40,044.2bn. The latest transaction was reported on 8 April 2026 (Holding update). Among the most active insiders: NIPPON ACTIVE VALUE FUND PLC. Every trade is openly available.
15
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate あすか製薬ホールディングス株式会社 Buy (bullish), based on 11 analysts. Average price target: JP¥3,619.
21Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,459 of 29,193 companies
57.0
score / 100
Value
37
Quality
77
FCF yld-59%
Earn yld6.1%
EV/EBITDA·
ROE9.5%
Gross mgn·
Net mgn32%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Asuka Pharmaceutical Holdings Co., Ltd. is a Japanese company specializing in the pharmaceutical sector, providing health-related products and services. It is listed on the Tokyo Stock Exchange under the symbol XTKS.